Systemic blood loss affects NF-κB regulatory mechanisms in the lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 273, Issue 1 17-1, 1997, Pages

  Moine, Pierre ^a   Shenkar, Robert ^a   Kaneko, Debra ^a   Le Tulzo, Yves ^a   Abraham, Edward ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute lung injury; Bcl 3; Hemorrhage; I B; Nuclear regulatory factor B; Oxygen radicals; Xanthine oxidase

Indexed keywords

CYTOPLASM PROTEIN; NUCLEAR PROTEIN; OXYGEN RADICAL; REGULATOR PROTEIN; XANTHINE OXIDASE;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLEEDING; ENZYME ACTIVITY; LUNG INJURY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0030750071     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.273.1.l185     Document Type: Article

References (56)

1. Abraham, E., S. Bursten, R. Shenkar, J. Allbee, R. Tuder, P. Weedson, D. M. Guidot, G. Rice, J. W. Singer, and J. E. Repine. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J. Exp. Med. 181: 569-575, 1995.
2. Abraham, E., A. A. Freitas, and A. A. Coutinho. Purification and characterization of intraparenchymal lung lymphocytes. J. Immunol. 144: 2117-2122, 1990.
3. Adamson, G. M., and R. E. Billings. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch. Biochem. Biophys. 294: 223-229, 1992.
4. Arenzana-Seisdedos, F., J. Thompson, M. S. Rodriguez, F. Bachelerie, D. Thomas, and R. T. Hay. Inducible nuclear expression of newly synthetized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15: 2689-2696, 1995.
5. Baeuerle, P. A., and T. Henkel. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179, 1994.
6. Beg, A. A., and A. S. Baldwin. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7: 2064-2070, 1993.
7. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13: 3301-3310, 1993.
8. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. Legall, A. Morris, and R. Spragg. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149: 818-824, 1994.
9. Blake, D. R., P. G. Winyard, and R. Marok. The contribution of hypoxia-reperfusion injury to inflammatory synovitis: the influence of reactive oxygen intermediates on the transcriptional control of inflammation. Ann. NY Acad. Sci. 723: 308-317, 1994.
10. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739, 1993.
11. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488, 1995.
12. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90: 2532-2536, 1993.
13. Chiao, P. J., S. Miyamoto, and I. M. Verma. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA 91: 28-32, 1994.
14. Dignam, J. D., P. L. Martin, B. S. Shatry, and R. F. Roeder. Eukariotic gene transcription with purified components. Methods Enzymol. 101: 582-598, 1983.
15. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Waltz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, and C. Haslett. Interleukin-8 and the development of adult respirstory distress syndrome in at-risk patient groups. Lancet 341: 643-647, 1993.
16. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB mediated inhibition. Nature 359: 339-342, 1992.
17. Fujita, T., G. P. Nolan, H. C. Liou, M. L. Scott, and D. Baltimore. The candidate proto-oncogene Bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7: 1354-1363, 1993.
18. Ganchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell 3: 1339-1352, 1992.
19. Gilmore, T. D., and P. J. Morin. The IκB proteins: members of a multifunctional family. Trends Genet. 9: 427-433, 1993.
20. Grimm, S., and P. A. Baeuerle. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem. J. 290: 297-308, 1993.
21. Hatada, E. N., A. Nieters, F. G. Wulczyn, M. Naumann, R. Meyer, G. Nucifora, T. W. McKeithan, and C. Scheidereit. The ankyrin repeat domains of the NF-κB precursor p105 and the proto-oncogene BCL3 act as specific inhibitors of the NF-κB DNA binding. Proc. Natl. Acad. Sci. USA 89: 2489-2493, 1992.
22. Henkel, T., T. Machleidt, T. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365: 182-185, 1993.
23. Hoffmann, H. P., R. Remy, C. Scheidereit, and A. P. G. M. Van Loon. Maintenance of NF-κB activity is dependent on protein synthesis and the continuous presence of external stimuli. Mol. Cell. Biol. 11: 259-266, 1991.
24. Imbert, V., R. R. Rupec, A. Livoisi, H. L. Pahl, E. B.-M. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P. A. Baeuerle, and J.-F. Peyron. Tyrosine phsophorylation of IκB-α activates NF-κB without proteolytic degradation of Iκ-α. Cell 86: 787-798, 1996.
25. Inoue, J., L. D. Kerr, A. Kakizuka, and I. M. Verma. IκBγ, a 70 kDa protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68: 1109-1120, 1992.
26. Ledebur, H., and T. Parks. Transcriptional regulation of the ICAM-1 gene by inflammatory cytokines in human endithelial cells: essential roles of a variant NF-κB site and p65 homodimers. J. Biol. Chem. 270: 933-943, 1995.
27. Liou, H. C., and D. Baltimore. Regulation of the NF-κB/Rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5: 477-487, 1993.
28. Liou, H. C., G. P. Nolan, S. Ghosh, T. Fujita, and D. Baltimore. The NF-κB p50 percursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO J. 11: 3003-3009, 1992.
29. McCord, J. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312: 159-163, 1985.
30. Milberg, J. A., D. R. Davis, K. P. Steinberg, and L. D. Hudson. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 273: 306-309, 1995.
31. Miyamoto, S., P. J. Chiao, and I. M. Verma. Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol. Cell. Biol. 14: 3276-3282, 1994.
32. Nolan, G. P., T. Fujita, K. Bhatia, C. Huppi, H. C. Liou, M. Scott, and D. Baltimore. The Bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation dependent manner. Mol. Cell. Biol. 13: 3557-3566, 1993.
33. Ohno, H., G. Takimoto, and T. W. McKeithan. The candidate proto-oncogene Bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60: 991-997, 1990.
34. Pahl, H. L., and P. A. Baeuerle. Oxygen and the control of gene expression. Bioessays 16: 497-502, 1994.
35. Qian, J., V. Bours, J. Manischewitz, R. Blackburn, U. Siebenlist, and H. Golding. Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-κB DNA binding proteins. J. Immunol. 152: 4183-4191, 1994.
36. Repine, J. E., and P. E. Parsons. Oxidant-antioxidant balance in endotoxin-induced oxidative injury and tolerance to oxidative injury. In: Endotoxin and the Lungs, edited by K. L. Brigham. New York: Dekker, 1994, p. 207.
37. Rice, N. R., and M. K. Ernst. In vivo control of NF-κB activation by IκBα. EMBO J. 12: 4685-4695, 1993.
38. Rice, N. R., M. L. MacKichan, and A. Israel. The precursor of NF-κB p50 has Iκfunctions. Cell 71: 243-253, 1992.
39. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995.
40. Schenck, H., M. Klein, W. Erdbrügger, W. Dröge, and K. Schulze-Osthoff. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA 91: 1672-1676, 1994.
41. Schreck, R., P. Rieber, and P. A. Baeuerle. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor nd HIV-1. EMBO J. 10: 2247-2258, 1991.
42. Schwartz, M. D., E. E. Moore, F. A. Moore, R. Shenkar, P. Moine, J. B. Haenel, and E. Abraham. Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit. Care Med. 24: 1285-1292, 1996.
43. Schwartz, M. D., J. E. Repine, and E. Abraham. Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am. J. Respir. Cell Mol. Biol. 12: 434-440, 1995.
44. Scott, M. L., T. Fujita, H. C. Liou, G. P. Nolan, and D. Baltimore. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7: 1266-1276, 1993.
45. Shenkar, R., and E. Abraham. Plasma from hemorrhaged mice activates CREB and increases cytokine expression in lung mononuclear cells through a xanthine oxidase-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 14: 198-206, 1996.
46. Shenkar, R., W. F. Coulson, and E. Abraham. Anti-transforming growth factor-β monoclonal antibodies prevent lung injury in hemorrhaged mice. Am. J. Respir. Cell Mol. Biol. 11: 351-357, 1994.
47. Shenkar, R., W. F. Coulson, and E. Abraham. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am. J. Respir. Cell Mol. Biol. 10: 290-297, 1994.
48. Shenkar, R., M. D. Schwartz, L. S. Terada, J. E. Repine, J. McCord, and E. Abraham. Hemorrhage activates NF-kB in murine lung mononuclear cells in vivo. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L729-L735, 1996.
49. Siebenlist, U., G. Franzoso, and K. Brown. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455, 1994.
50. Sun, S., P. A. Ganchi, D. A. Ballard, and W. C. Greene. NF-κB controls expression of inhibitory IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915, 1993.
51. Sun, S., J. Elwood, and W. C. Greene. Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16: 1058-1065, 1996.
52. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J. M. Dayer. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145: 1016-1022, 1992.
53. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. IκBα regulates the persistent response in a biphasic activation of NF-κB. Cell 80: 573-582, 1995.
54. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9: 2723-2735, 1995.
55. Wulczyn, F. G., M. Naumann, and C. Scheidereit. Candidate proto-oncogene Bcl-3 encodes a subunit specific inhibitor of transcription factor NF-κB. Nature 358: 597-599, 1992.
56. Zabel, U., T. Henkel, M. Dos Santos Silva, and P. A. Baeuerle. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J. 12: 201-211, 1993.